Skip to content
Business

Siemens Posts Record Orders and Free Cash Flow and Raises Its Mid-Term Targets

Siemens booked record fourth-quarter orders of €34.8bn, up 58%, and record free cash flow of €12.1bn, raised its dividend to €5.50 and lifted mid-term growth targets ahead of a Healthineers spin-off.

The Siemens name in metal letters on a stone block on the forecourt of the company's glass-fronted headquarters in Munich, beside a tall steel sculpture.
Photo: Álvaro de la Paz Franco / Wikimedia Commons, CC0

Siemens booked record quarterly orders of €34.8bn on Thursday, up 58%, and record free cash flow of €12.1bn for its fiscal year to September. It raised its dividend to €5.50, lifted its mid-term growth targets and set out plans to hand part of its Siemens Healthineers stake directly to shareholders. Earnings per share for the year beat the company's own raised guidance.

The figures arrive before the Xetra open on a stock that has lagged this autumn. Siemens closed last week at €263.65, about 9% below its end-August level, having dropped 5.12% in the week to 23 October to a weekly close of €256.80.

Fiscal 2026 in numbers

  • €34.8bn fourth-quarter orders, up 58%
  • €12.1bn free cash flow for the year, a record
  • €5.50 proposed dividend, up from €5.35

A Record Fourth Quarter

In the three months to 30 September revenue rose 11% to €23.7bn, or 10% on a comparable basis, and the book-to-bill ratio, orders against revenue, reached 1.47. Profit in the Industrial Business rose 22% to a record €3.9bn, a margin of 16.8%. Net income rose 32% to €2.4bn and earnings per share before purchase price allocation (EPS pre-PPA) were €3.01. Free cash flow for the quarter was a record €5.6bn.

Mobility and Smart Infrastructure led the growth in orders, the company said, and Smart Infrastructure made the largest contribution to revenue. Over the year Siemens pointed to strong demand for electrification, digitalisation and industrial AI, and to its position in fast-growing markets such as data centres.

Siemens: share price, chart and news

The reception building of the Siemens Campus in Erlangen, with the Siemens name on its facade and a tall silver sculpture in front.
The reception building of the Siemens Campus in Erlangen, with the Siemens name on its facade and a tall silver sculpture in front. Photo: Hans-Rudi der Letzte / Wikimedia Commons, CC BY-SA 4.0

The Full Year Beats Guidance

Fiscal year to September20262025
Orders (comparable)€108.2bn€88.4bn
Revenue (comparable)€83.4bn€78.9bn
Profit Industrial Business€13.3bn€11.8bn
Industrial Business margin16.3%15.4%
Free cash flow€12.1bn€10.8bn
EPS pre-PPA€11.76€12.95
Dividend per share€5.50€5.35

Comparable orders rose 25% and the order backlog grew to €143bn, from €117bn a year earlier. Revenue was up 8% on a comparable basis. EPS pre-PPA of €11.76 came in above the €11.20 to €11.50 range Siemens had set when it raised guidance after the third quarter.

Net income fell to €9.5bn from €10.4bn, but the earlier figure had included a €2.1bn gain on the sale of Innomotics. Digital business revenue rose 16% to €10.9bn. Software revenue in the Digital Industries unit grew 13% on a comparable basis to €7.2bn, and annual recurring revenue rose 12% to €6.1bn.

Chief executive Roland Busch called it an outstanding year and said "Industrial AI is an exceptional growth opportunity".

Higher Targets and the Healthineers Spin-Off

Siemens raised its mid-term ambition to comparable revenue growth of 7% to 11% a year, from 6% to 9%, and to double-digit annual growth in EPS pre-PPA, up from high single digits.

It also plans to transfer 34.1% of its stake in Siemens Healthineers to its own shareholders through a direct spin-off during fiscal 2027, at one Healthineers share for every two Siemens shares. Siemens will then deconsolidate Healthineers. It expects the medical technology business to be classified as a discontinued operation from the first quarter of fiscal 2027.

Two days before the results, on 10 November, Siemens agreed to buy Lauterbach, a maker of debugging and trace tools for embedded systems based in Hoehenkirchen, near Munich. Lauterbach has about 170 employees and had revenue of roughly €60m in 2025. No price was disclosed, and the deal is expected to close in the first half of 2027.

The 2027 Outlook

For fiscal 2027 Siemens expects comparable revenue growth of 9% to 11% and EPS pre-PPA of €10.20 to €10.80, both excluding Healthineers. On the same basis, fiscal 2026 EPS pre-PPA was €9.27, so the guidance implies growth of about 10% to 16.5%.

Fiscal 2027 targets by business

  • Digital Industries: comparable revenue growth of 8% to 12%, profit margin of 20% to 22%
  • Smart Infrastructure: comparable revenue growth of 11% to 13%, profit margin of 19.5% to 20.5%
  • Mobility: comparable revenue growth of 6% to 8%, profit margin of 8% to 10%
  • Group book-to-bill ratio above 1

The outlook excludes charges from legal and regulatory matters. With the backlog at €143bn, investors will judge whether the new growth range holds once Healthineers leaves the group, and how quickly the spin-off can be completed. The first verdict comes when Xetra trading opens.

Sources

Related stories

Investing

Stoxx 600 Hits a Record as Europe's Value Tilt Pays Off in the Nvidia Shock

The Stoxx 600 closed at a record 664.01 on 12 November as energy, health care and telecoms offset losses in chip and software stocks after Nvidia's CEO resigned and Taiwan's Taiex…

Markets

ABB Shares Slide Despite a Record 40% Jump in Orders as AI Jitters Hit Electrification

ABB shares fell as much as 6.7%, their steepest drop since April 2025, even as third-quarter orders jumped 40% to a record $12.1bn. AI worries also hit Siemens and Schneider…

Markets

European Stocks Suffer Their Worst Week Since April on Oil and Rate Fears

The STOXX 600 lost about 2.2% this week, its worst run since April, as oil near $110 revived inflation fears and the ECB raised rates. A Friday rally led by aerospace and banks…

Business

Allianz Posts a Record €14.1bn Nine-Month Profit and Raises Its 2026 Outlook

Allianz lifted the top of its 2026 operating profit range to about €18.6bn after a record €14.1bn for nine months, up 7.8%, as asset management profit jumped 35% in the third…

Business

Québecor Makes a C$31bn Cash-and-Share Bid for Telus, Which Warns of Regulatory Risk

Québecor has offered C$6.35 in cash plus 0.17 of its own shares for each Telus share, a bid worth about C$31bn. The Telus board says the price falls short and the regulatory risk…

Business

Tyson Foods Shares Jump 8.7% as Beef Outlook Outweighs a $74m Quarterly Loss

Tyson Foods posted a $74m fourth-quarter net loss and adjusted EPS of $0.61, down 47%, yet its shares closed 8.7% higher on Monday as its 2027 beef outlook pointed to far smaller…

Business

Roche Wins FDA Approval for Breast Cancer Pill Wilserdly After 62% Cut in Progression Risk

The FDA approved Roche's all-pill Wilserdly combination for ESR1-mutated advanced breast cancer after it cut the risk of progression or death by 62%. A ruling on early-stage use is…

Business

ULA Loses Its First Mission as Vulcan Rocket Fails With 40 Amazon Leo Satellites on Board

United Launch Alliance's Vulcan rocket failed about 10 minutes after lift-off on Sunday, and all 40 Amazon Leo satellites were lost. Amazon fell 3.3% on Monday as space stocks…